|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +11.33% |
|
-.--% | +221.15% |
| 01/06 | Revium Rx. Announces CFO Changes, Effective May 27, 2026 | CI |
| 15/05 | Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 102M 88.45M 81.51M 76.29M 143M 9.73B 145M 962M 375M 4.74B 384M 376M 16.4B | P/E Ratio 2024 |
-11.7x | P/E Ratio 2025 | -2.35x |
|---|---|---|---|---|---|
| Enterprise Value | 99.8M 86.19M 79.43M 74.35M 139M 9.49B 141M 938M 366M 4.62B 375M 367M 15.99B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +11.33% | ||
| 3 months | +11.33% | ||
| 6 months | +221.15% | ||
| Current year | +221.15% |
| Current year | 1.05 | 1.67 | |
| 1 year | 0.52 | 1.67 | |
| 3 years | 0.3 | 1.67 | |
| 5 years | 0.3 | 2.31 | |
| 10 years | 0.3 | 50 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Avraham
CEO | Chief Executive Officer | - | 22/05/2025 |
Igor Bluvstein
DFI | Director of Finance/CFO | 46 | 27/05/2026 |
Inna Martin
CEO | Chief Executive Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yoram Druker
BRD | Director/Board Member | - | - |
| Chairman | - | 14/04/2026 | |
Inna Martin
BRD | Director/Board Member | 51 | - |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.5M -3.03M -2.79M -2.61M -4.89M -333M -4.97M -32.94M -12.84M -162M -13.15M -12.87M -561M | -13.45M -11.62M -10.7M -10.02M -18.78M -1.28B -19.07M -126M -49.28M -622M -50.47M -49.4M -2.15B |
| Net Debt | -5.28M -4.56M -4.2M -3.93M -7.37M -502M -7.48M -49.6M -19.34M -244M -19.81M -19.39M -845M | -2.61M -2.25M -2.08M -1.94M -3.64M -248M -3.7M -24.52M -9.56M -121M -9.79M -9.58M -418M |
Employees
5
Sector
-
- Stock Market
- Stocks
- RVRC Stock
Select your edition
All financial news and data tailored to specific country editions
















